Free tool
Drug Trial Radar: Endocrinology and women's health
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
5
Active, not recruiting, industry sponsors, Endocrinology and women's health, Phase 3
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed328
5 trials
Showing 1 to 5, recently updated first.
- Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.Pivotal-lookingActive, not recruiting
Granata Bio CorporationIndustry
NCT07216742 · 659 participants (planned) · Start Nov 1, 2025 · Primary completion Nov 2028
Drug: hMG subcutaneous injection; Placebo · For: Infertility (IVF Patients)
Sites: Encino, California; Norwalk, Connecticut; Newark, Delaware · 16 sites in all
- A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult ParticipantsPivotal-lookingActive, not recruiting
AbbVieAbbVie (ABBV)
NCT06345339 · 2,701 participants · Start Apr 26, 2024 · Primary completion Sep 2027
Drug: Armour Thyroid; Levothyroxine · For: Hypothyroidism
Sites: Birmingham, Alabama; Bonita, California; Burbank, California · 139 sites in all
- Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe PainPivotal-lookingActive, not recruiting
AbbVieAbbVie (ABBV)
NCT04333576 · 800 participants (planned) · Start Aug 10, 2020 · Primary completion Jul 2027
Drug: Elagolix; Placebo and 1 more · For: Endometriosis
Sites: Anniston, Alabama; Birmingham, Alabama; Dothan, Alabama · 179 sites in all
- A Clinical Study of KLH-2109 in Patients With EndometriosisPivotal-lookingActive, not recruiting
Kissei Pharmaceutical Co., Ltd.Industry
NCT07015268 · 288 participants (planned) · Start Jun 9, 2025 · Primary completion Nov 2027
Drug: KLH-2109; Leuprorelin acetate · For: Endometriosis
Sites: Multiple Locations, Japan
- Comparative Efficacy, Safety, PK, and Immunogenicity StudyPivotal-lookingActive, not recruiting
Luye Pharma Group Ltd.Industry
NCT05853354 · 392 participants (planned) · Start Apr 5, 2023 · Primary completion Jul 30, 2025
Drug: Denosumab · For: Osteoporosis, Postmenopausal
Sites: Thousand Oaks, California; Hialeah, Florida; Fort Worth, Texas · 39 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.